Skip to content

Clinical trials

Myelodysplastic Syndromes trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Country / region: Greece Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20071
20081
20101
20113
20132
20143
20151
20161
20171
20181
20194
20202
20211
20222
20233
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated7
Active, not recruiting6
Recruiting3
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals11
Celgene6
Amgen2
Bristol-Myers Squibb2
Takeda2
Agios Pharmaceuticals, Inc.1
Associazione Qol-one1
Celgene Corporation1
European Organisation for Research and Treatment of Cancer - EORTC1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes34
Leukemia, Myeloid, Acute9
Anemia8
Lymphoma, Non-Hodgkin5
Multiple Myeloma5
Myeloproliferative Disorders4
Thrombocytopenia4
Leukemia, Myelomonocytic, Chronic3
Lymphoma3
Lymphoma, Large B-Cell, Diffuse3

Trials

Showing 26 to 34 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.